# Progress Note 04 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Dwight D. Eisenhower (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET015-SYN-TD
- Date: 1956-04-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Russell Okonkwo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient, with control of anterior nasal hemorrhage (CPT 30901)

## Chief complaint

Nosebleed this morning that took about 25 minutes to stop. **S**

## History of present illness

Mr. Eisenhower is a 65-year-old man about six and a half months after an anterior myocardial infarction treated with a drug-eluting stent, on aspirin 81 mg and ticagrelor 90 mg twice daily, who asked for a same-day visit. This morning, after blowing his nose, his right nostril began to bleed. He leaned forward and pinched his nose, but it took about 25 minutes to stop, and he soaked several handkerchiefs. Three days ago he had a brief bleed from the same side that stopped within five minutes. The office heating has been running high and his nose has felt dry and crusted for a week. He has had no bleeding from the gums, easy bruising, black stools, or blood in the urine, and no lightheadedness. He takes no ibuprofen or other NSAIDs and no supplements. He took his morning aspirin and ticagrelor and asks whether he should stop them. **S**

| Element | Detail |
|---|---|
| Onset | This morning, after blowing his nose; a brief bleed three days ago |
| Location | Right nostril only; no blood running down the throat |
| Duration | About 25 minutes with pressure |
| Severity | Moderate; several handkerchiefs; no lightheadedness |
| Context | Dry indoor heating; dual antiplatelet therapy after a coronary stent |
| Modifying factors | Leaning forward and pinching the soft part of the nose |
| Associated signs and symptoms | Nasal dryness and crusting. Denies gum bleeding, bruising, melena, hematuria, chest pain, and dizziness |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fatigue, fever, or lightheadedness |
| Ears, nose, mouth, and throat | Positive | Right-sided nosebleed; nasal dryness and crusting for a week; no blood in the throat |
| Cardiovascular | Negative | No chest pain, palpitations, or breathlessness |
| Gastrointestinal | Negative | No black or bloody stools |
| Genitourinary | Negative | No blood in the urine |
| Hematologic | Negative | No easy bruising or gum bleeding |

6 systems reviewed. **S**

## Current medications

- Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily **S**
- Ticagrelor 90 mg oral tablet, one tablet by mouth twice daily **S**
- Atorvastatin 80 mg oral tablet, one tablet by mouth daily **S**
- Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth daily **S**
- Lisinopril 10 mg oral tablet, one tablet by mouth daily **S**
- Ezetimibe 10 mg oral tablet, one tablet by mouth daily **S**
- Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tablet **S**

## Allergies

- No known allergy **S**

## Objective

BP 146/86 mmHg; pulse 74 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 77.9 kg; BMI 24.6 kg/m². All vital signs are synthetic.

Hemoglobin: 14.3 g/dL; Platelets: 221 10*3/uL. All results are synthetic.

## Change since baseline

- Hemoglobin: 14.6 g/dL at baseline, 14.3 g/dL at this visit **S**
- Platelets: 228 10*3/uL at baseline, 221 10*3/uL at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well-appearing, anxious about the bleeding, not pale |
| Nose | Dry, crusted mucosa of the right anterior septum with a visible prominent vessel and fresh clot in Kiesselbach's area; no active bleeding after the clot was cleared; left side normal |
| Oropharynx | No blood in the posterior pharynx |
| Cardiovascular | Regular rhythm; no murmur |
| Skin | No bruising or petechiae |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Anterior epistaxis, right side** (R04.0). A bleed from a visible vessel in Kiesselbach's area, made more likely by dry air and made longer by dual antiplatelet therapy. There is no sign of a posterior bleed, the hemoglobin is 14.3 g/dL against 14.6 g/dL in January, and the platelet count is normal. **S**
   - After topical anesthetic and oxymetazoline, the visible vessel on the right was cauterized with silver nitrate; the left side was not treated.
   - Petroleum jelly to the inside of the right nostril twice daily and saline nasal spray several times a day for two weeks; a humidifier in the office.
   - No nose blowing, heavy lifting, or straining for one week.
   - If it bleeds again: lean forward and pinch the soft part of the nose firmly for 15 minutes by the clock. Go to the emergency department if bleeding lasts more than 20 minutes despite pressure, runs down the throat, or causes lightheadedness.
2. **Myocardial infarction with a drug-eluting stent, about six and a half months ago** (I25.2). Stopping antiplatelet therapy within the first year after a stent carries a risk of stent thrombosis that outweighs the risk of a controllable anterior nosebleed. **S**
   - Continue aspirin 81 mg and ticagrelor 90 mg twice daily without interruption.
   - Avoid NSAIDs; use acetaminophen for pain.
3. **Essential hypertension** (I10). Blood pressure 146/86 mmHg today, raised by anxiety about the bleeding; it was 124/76 mmHg in March. **S**
   - No change; recheck at the review next month and send two weeks of home readings.

## Guideline basis

- 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes (2025), American College of Cardiology and American Heart Association
- Clinical Practice Guideline: Nosebleed (Epistaxis) (2020), American Academy of Otolaryngology-Head and Neck Surgery Foundation

## Follow-up

- Coronary disease review next month as planned. Return the same day or go to the emergency department for a nosebleed that does not stop with 20 minutes of pressure. **S**
- Next scheduled visit 1956-05-11: seven-month coronary disease review after return to full-time work. **S**
